Local Institution - 4103

Madrid 28041

0 studies enrolling now · 3 studies all time

What they study most

Advanced Solid Tumor, Locally Advanced Solid Tumor, Locally Advanced Solid Tumors, MET Gene Alterations, Metastatic Solid Tumor, Metastatic Solid Tumors

Studies at this site

• A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements — Recruiting now
• Study of TPX-0022 in Patients With Advanced NSCLC, Gastric Cancer or Solid Tumors Harboring Genetic Alterations in MET — Running, not enrolling
• A Phase 1 Study to Assess the Effect of Hepatic Impairment on the Pharmacokinetics of Repotrectinib in Advanced Cancer Patients — Withdrawn before enrolling